BDNF and Huntington disease: We determined whether fingolimod, a drug known to modulate neurotrophin levels in the CNS, can augment BDNF levels and exert a protective effect in the R6/2 mouse model of HD, particularly when treatment is initiated at presymptomatic stages prior to the onset of motor symptoms and striatal neuronal degeneration.